SAN DIEGO, April 20, 2015 (GLOBE NEWSWIRE) -- ICON Vapor, Inc. (OTCQB:ICNV) is pleased to announce that the company has received approval from OTC Markets and Icon Vapor, Inc. (ICNV) has been upgraded to the OTCQB markets as of Friday April 17th.
Icon Vapor's CEO, Dan Balsiger stated, "We are extremely pleased to inform our shareholders that Icon Vapor, Inc. has been upgraded to the OTCQB market; this is an extremely significant milestone for the company and the shareholders, and one we have worked extremely hard at accomplishing. It is an important step completed in our company's growth plans for 2015 and beyond."
Dan went on to say, "Elevating the Company from the PK Markets to the QB Markets will provide clearer information to our shareholder base, which is extremely important to us, and we look forward to sharing other exciting events as Quarter 2 progresses."
About ICON Vapor, Inc.:
Headquartered in San Diego, California, ICON Vapor, Inc. engages in the manufacture and distribution of Ultra Premium Vapor Products. The company offers a wide variety of Vapor Products, Vape Pens & E-Liquids that are made in the USA, all branded under the ICON Vapor Products line. For further information please contact the Company at: ir@iconvapor.com.
Safe Harbor Statement:
This press release may contain forward looking statements and or observations which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues as well as any payment of dividends on our stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties include but not limited to information as contained within the Company's most current quarterly reports, annual reports, and or other such filings as may be accessed through the OTC website. Furthermore, the Company disclaims any intention or obligation to update or revise any such forward looking statements, whether as a result of new information, future events, or otherwise. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new product lines noting there is no assurance that we will generate enough revenues to offset those costs. Additional product offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the variables as associated with the general business channel we are operating in, the impact of which cannot be predicted at this time including risks as associated with our product and recent FDA pronouncements.
Investor Contact Information: 858.564.9513
